Anticoagulation in venous thromboembolism in Behçet’s syndrome: friend or foe?
Saved in:
Main Authors: | Rosaria Talarico, Marta Mosca, Raffaele De Caterina, Alessandro Celi, Marco De Carlo, Laura Carrozzi, Federica Di Cianni, Elisabetta Casto, Rosalinda Madonna, Andrea Maria D'Armini, Roberta Pancani |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-12-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/10/4/e004943.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Status of New Anticoagulants in the Management of Venous Thromboembolism
by: Roberto C. Montoya, et al.
Published: (2012-01-01) -
Global Research Hotspots in Venous Thromboembolism Anticoagulation: A Knowledge-Map Analysis from 2012 to 2021
by: Jia Wang, et al.
Published: (2023-01-01) -
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
by: Raffaele De Caterina, et al.
Published: (2019-03-01) -
Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study
by: Ahmed El-Bardissy, et al.
Published: (2025-01-01) -
Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials
by: Weijie Fu, et al.
Published: (2025-01-01)